# NAPROXEN
> **ANDA216504** · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA · Approved 2025-10-03
## Drug
- **FDA Application Number:** ANDA216504
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** NAPROXEN
- **Generic name:** NAPROXEN
- **Active ingredients:** NAPROXEN
- **Dosage form:** SUSPENSION
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** AUROBINDO PHARMA
- **Manufacturer:** Aurobindo Pharma Limited
- **First approval:** 2025-10-03
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216504)
---
*AI Analytics · CC0 1.0*